Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma

Published:2019-07-18 Issue:14 Volume:60 Page:3434-3441
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Yamaguchi Junko¹,Chinen Yoshiaki¹,Takimoto-Shimomura Tomoko¹,Nagata Hiroaki²,Muramatsu Ayako²,Kuriyama Kodai²,Ohshiro Muneo²,Hirakawa Yoshiko²,Iwai Toshiki²,Uchiyama Hitoji²,Uoshima Nobuhiko³,Kaneko Hiroto⁴,Nakao Mitsushige⁵,Tsukamoto Taku¹,Shimura Yuji¹,Kobayashi Tsutomu¹,Horiike Shigeo¹,Yokota Isao⁶,Kuroda Junya¹,

Affiliation:

1. Department of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan;

2. Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan;

3. Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan;

4. Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan;

5. Department of Internal Medicine, Otsu Municipal Hospital, Otsu, Japan;

6. Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan

Funder

National Cancer Center Research and Development Fund of Japan

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1636982

Reference36 articles.

1. The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma

2. How I manage patients with relapsed/refractory diffuse large B cell lymphoma

3. Thrombocytopenia After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: An Unresolved Problem and Possible Approaches to Resolve It

4. Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors

5. Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview;Cancers;2023-11-06

2. Enhancing CD34+ Cell Mobilization and Engraftment after Autologous Hematopoietic Stem Cell Transplantation via Adjustment of Granulocyte Colony-Stimulating Factor Dose and Period, a Single Center Experience;Journal of Advances in Medical and Biomedical Research;2023-10-01

3. Circulatory miR-155 correlation with platelet and neutrophil recovery after autologous hematopoietic stem cell transplantation, a multivariate analysis;International Journal of Hematology;2021-04-24

4. Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma;Leukemia & Lymphoma;2020-10-15

5. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma;Annals of Hematology;2020-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3